Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-24-021198

Chief Financial Officer gave up 1,053 shares (to pay taxes)

  • Chief Financial Officer acquired 4,329 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Foster Jonathan P. Chief Financial Officer 2024-06-22 Option exercise +4,329 12,416 D: show line 1 in the form
Foster Jonathan P. Chief Financial Officer 2024-06-22 Shares withheld for taxes −1,053 $3.74 $3,938 11,363 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Foster Jonathan P. Chief Financial Officer 2024-06-22 Option exercise · Restricted Stock Units −4,329 64,837 D: show line 3 in the form
Loading xslF345X05/rdgdoc.xml…